Adjuvant Therapy Market Report 2024 (Global Edition)

Global Adjuvant Therapy Market Report 2024 Market Size Split by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Others), by Drug Class (Chemotherapy, Immunotherapy, Target...

Adjuvant Therapy Market Report Description

We have various report editions of Adjuvant Therapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Adjuvant Therapy Market Insights Video

Competitive Landscape of the Adjuvant Therapy Market

The competitive context of the adjuvant therapy industry offers information broken down by competition. Several important pharmaceutical companies are present in the adjuvant therapy industry. These businesses are pouring a lot of money into R&D to come up with new medicines and enhance the ones that are already out there. Companies frequently engage in mergers and collaborations in an effort to broaden their goods offerings and customer bases. More and more biotech companies are joining the market, creating innovative treatments and personalized health solutions, which is increasing competition.

In September 2024, Sanofi signed an exclusive licensing agreement with French clinical-stage biotechnology company Orano Med, a division of the Orano Group, developing lead-212 (212Pb) radioligand therapies (RLTs) against cancer; RadioMedix, Inc., a US clinical-stage biotechnology company developing radiopharmaceuticals for PET imaging and targeted alpha therapy (TAT) against unmet medical needs in cancer, has also signed a license agreement with Sanofi. (Source: https://www.sanofi.com/en/media-room/press-releases/2024/2024-09-12-05-00-00-2944919 In September 2024, Merck, which operates primarily in the US and Canada, announced that the CHMP of the European Medicines Agency had adopted positive opinions recommending approval of KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for two indications in gynecologic cancers. (Source: https://www.merck.com/news/merck-receives-positive-eu-chmp-opinions-for-keytruda-pembrolizumab-regimens-as-treatment-for-patients-with-two-types-of-gynecologic-cancers/ In August 2024, Pfizer Inc. unveiled PfizerForAll, a user-friendly digital platform meant to enable seamless access to healthcare and management of health and wellness for people throughout the United States. (Source: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-launches-pfizerforalltm-digital-platform-helps)

Top Companies Market Share in Adjuvant Therapy Industry: (In no particular order of Rank)

• Roche
• Novartis AG
• Pfizer Inc.
• Sanofi
• AstraZeneca
• Bristol Myers Squibb
• Merck & Co.
• Inc.
• GlaxoSmithKline plc
• Eli Lilly and Company
• Johnson & Johnson
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Adjuvant Therapy Market

Which Region Dominates the Adjuvant Therapy Market in 2024?

According to Cognitive Market Research, North America currently dominates the adjuvant therapy market, and the region is expected to have significant growth during the projected period. This is because of a sophisticated healthcare system, rising cancer rates, and excessive healthcare expenditure. Additionally, the region is anticipated to experience substantial growth during the projected period, driven by its emphasis on research and development and strong adoption of novel treatments.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR) due to it putting more money into healthcare, more people getting cancer, and better healthcare facilities. More people in the area are also learning about advanced cancer treatments and getting access to more modern medical services. The adjuvant therapy market in Asia-Pacific is growing quickly because of things like the low cost of treatments, helpful government programs, and the rise of new pharmaceutical companies.

The current report Scope analyzes Adjuvant Therapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Adjuvant Therapy

According to Cognitive Market Research, the global adjuvant therapy market size was estimated at USD 2642.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1056.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the adjuvant therapy market with a market size of USD 833.88 million in 2024 and is projected to grow at a CAGR of 12.2% during the forecast period. The U.S. market's stringent governmental healthcare regulations.
• The Canada adjuvant therapy market had a market share of USD 126.83 million in 2024 and is projected to grow at a CAGR of 13.2% during the forecast period. Canada’s rising cancer awareness among populations.
• The Mexico adjuvant therapy market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 96.18 million in 2024.

Europe Adjuvant Therapy

According to Cognitive Market Research, the global adjuvant therapy market size was estimated at USD 2642.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 792.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.7% from 2024 to 2031.

• The United Kingdom adjuvant therapy market had a market share of USD 133.17 million in 2024 and is projected to grow at a CAGR of 13.5% during the forecast period. In the UK, adjuvant therapy sales witness an upswing due to the nation's rising demand for innovative technology.
• The France adjuvant therapy market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 72.92 million in 2024.
• According to Cognitive Market Research, the German adjuvant therapy market size was valued at USD 156.95 million in 2024 and is projected to grow at a CAGR of 12.9% during the forecast period. In Germany, adjuvant therapy surged due to the presence of major market players.
• The Italy adjuvant therapy market is projected to witness growth at a CAGR of 12.1% during the forecast period, with a market size of USD 68.17 million in 2024.
• The Russia adjuvant therapy market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 122.86 million in 2024.
• The Spain adjuvant therapy market is projected to witness growth at a CAGR of 11.8% during the forecast period with a market size of USD 65.00 million in 2024
• The Luxembourg adjuvant therapy market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 24.57 million in 2024.
• The Portugal adjuvant therapy market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 16.65 million in 2024.
• The Greece adjuvant therapy market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 9.51 million in 2024.
• The Rest of Europe's adjuvant therapy market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 122.86 million in 2024.

Asia Pacific Adjuvant Therapy

According to Cognitive Market Research, the global adjuvant therapy market size was estimated at USD 2642.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 607.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2031.

• According to Cognitive Market Research, the China adjuvant therapy market size was valued at USD 273.47 million in 2024 and is projected to grow at a CAGR of 15.7% during the forecast period. Adjuvant therapy surged in China due to heightened awareness of cancer and the benefits of this therapy in the industry.
• The Japan adjuvant therapy market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 83.86 million in 2024.
• The India adjuvant therapy market had a market share of USD 72.92 million in 2024 and is projected to grow at a CAGR of 18.0% during the forecast period. India's rising emphasis on vaccination.
• The South Korean adjuvant therapy market is projected to witness growth at a CAGR of 15.3% during the forecast period, with a market size of USD 60.77 million in 2024.
• The Australian adjuvant therapy market is projected to witness growth at a CAGR of 15.9% during the forecast period, with a market size of USD 31.60 million in 2024.
• The Southeast Asia adjuvant therapy market is projected to witness growth at a CAGR of 17.2% during the forecast period, with a market size of USD 41.93 million in 2024.
• The Rest of Asia Pacific adjuvant therapy market is projected to witness growth at a CAGR of 16.0% during the forecast period, with a market size of USD 43.15 million in 2024.

South America Adjuvant Therapy

According to Cognitive Market Research, the global adjuvant therapy market size was estimated at USD 2642.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 132.11 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil adjuvant therapy market size was valued at USD 56.54 million in 2024 and is projected to grow at a CAGR of 14.2% during the forecast period. Adjuvant therapy flourished in Brazil due to increasing disposable income.
• Argentina's adjuvant therapy market had a market share of USD 22.19 million in 2024 and is projected to grow at a CAGR of 14.5% during the forecast period. Argentina's rising government initiatives.
• Colombia’s adjuvant therapy market is projected to witness growth at a CAGR of 13.4% during the forecast period, with a market size of USD 11.76 million in 2024.
• Peru’s adjuvant therapy market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 10.83 million in 2024.
• Chile’s adjuvant therapy market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 9.51 million in 2024.
• The Rest of Latin America's adjuvant therapy market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 21.27 million in 2024.

Middle East and Africa Adjuvant Therapy

According to Cognitive Market Research, the global adjuvant therapy market size was estimated at USD 2642.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 52.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031..

• The GCC Countries’ adjuvant therapy market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 22.62 million in 2024. Adjuvant therapy sales flourish due to the presence of major market players.
• The Egypt adjuvant therapy market is projected to witness growth at a CAGR of 14.2% during the forecast period, with a market size of USD 5.55 million in 2024.
• The South Africa adjuvant therapy market is projected to witness growth at a CAGR of 14.9% during the forecast period, with a market size of USD 8.35 million in 2024. Adjuvant therapy sales flourished in South Africa due to increasing regulatory support.
• The Turkey adjuvant therapy market is projected to witness growth at a CAGR of 13.4% during the forecast period, with a market size of USD 4.54 million in 2024.
• The Nigeria adjuvant therapy market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 5.55 million in 2024.
• The Rest of the MEA adjuvant therapy market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 6.24 million in 2024.

Adjuvant Therapy Market Analysis

How are Segments Performing in the Global Adjuvant Therapy Market?

Adjuvant Therapy Market Cancer Type Segment Analysis

According to Cognitive Market Research, lung cancer is likely to dominate the adjuvant therapy market over the forecast period. Because it’s very common and getting worse around the world. Early detection, targeted therapies, and the growing need for all-around treatment choices are some of the factors that are driving growth. The high death rate from lung cancer also makes it clear that successful adjuvant therapies are needed.

The breast cancer is the fastest-growing segment in the adjuvant therapy market. Because it is becoming more common around the world. Adjuvant therapy is becoming more popular because of better treatment plans, personalized medicine, and focused therapies. This segment of the adjuvant therapy market is growing very quickly because more people are learning about breast cancer and spending more on health care.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Adjuvant Therapy Industry. Request a Free Sample PDF!

Adjuvant Therapy Market Drug Class Segment Analysis

According to Cognitive Market Research, the chemotherapy segment holds the largest share of the market. This is because it is commonly used to treat many types of cancer. Because chemotherapy shrinks tumors and stops them from coming back, and it can be used with other treatments, it is the most popular choice. Also, ongoing improvements in chemotherapy drugs and easy access to them further its growth in the adjuvant therapy market.

In the adjuvant therapy market, immunotherapy has been growing quickly. Because it makes the immune system stronger, which helps kill cancer cells. Immunotherapy's ability to treat cancers that don’t respond to standard treatments and its lack of side effects have made immunotherapy more widely used and accepted.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Adjuvant Therapy Application Segment Analysis

Adjuvant Therapy Market Application Segment Analysis

According to Cognitive Market Research, the hospital segment holds the largest market share. Because of their well-developed healthcare system, access to state-of-the-art medicines, and abundance of specialized cancer treatment centers. Because hospitals typically offer a full range of cancer therapies, including immunotherapy, chemotherapy, and surgery, they are the first choice for patients looking for adjuvant therapy, which boosts their market growth.

In the adjuvant therapy market, the rapidly growing sector is medical institutions. Because of well-funded cancer research, state-of-the-art treatment centers, and expert medical attention. The expansion of adjuvant therapy adoption and availability is greatly influenced by medical institutions, which play a crucial role in researching innovative therapies and offering multimodal treatment alternatives.

• Hospital
• Medical Institution
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion